NASDAQ : NSPR
InspireMD, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.45 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.92M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 20.92M |
| Enterprise Value | -6.48M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 46.49M |
| Shares Outstanding | 46.49M |
| Shares Change (YoY) | +63.52% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 10.63% |
| Owned by Institutions (%) | 19.66% |
| Float | 28.72M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.93 |
| Forward PS | 1.77 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.80 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -202.81% |
| Return on Assets (ROA) | -85.85% |
| Return on Invested Capital (ROIC) | -115.02% |
| Return on Capital Employed (ROCE) | -153.04% |
| Weighted Average Cost of Capital (WACC) | 8.08% |
| Revenue Per Employee | $85,362 |
| Profits Per Employee | -$413,244 |
| Employee Count | 127 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 3.09 |
Taxes
| Measure | Value |
|---|
| Income Tax | 63,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -80.18% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 1.07 |
| Relative Strength Index (RSI) | 30.19 |
| Average Volume (20 Days) | 261,879 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 80,900 |
| Short Previous Month | 22,466 |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 0.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 10.84M |
| Gross Profit | 1.96M |
| Operating Income | -53.56M |
| Pretax Income | -52.42M |
| Net Income | -52.48M |
| EBITDA | -52.98M |
| EBIT | -53.56M |
| Loss Per Share | -$0.65 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 30.42M |
| Total Debt | 3.03M |
| Net Cash | 27.40M |
| Net Cash Per Share | $0.59 |
| Equity (Book Value) | 31.51M |
| Book Value Per Share | 0.67 |
| Working Capital | 26.98M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -41.21M |
| Capital Expenditures | -1.25M |
| Depreciation & Amortization | 578,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -42.46M |
| FCF Per Share | -$0.91 |
Margins
| Measure | Value |
|---|
| Gross Margin | 18.05% |
| Operating Margin | -494.03% |
| Pretax Margin | -483.53% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -63.52% |
| Shareholder Yield | n/a |
| Earnings Yield | -143.65% |
| FCF Yield | -202.97% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.33 |
| Price Target Difference | 640.00% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 235.08% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -9.88 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |